JAMES SPICER

James Spicer is Professor of Experimental Cancer Medicine in the School of Cancer and Pharmaceutical Studies of King’s College London, and Honorary Consultant in Medical Oncology at Guy’s and St. Thomas’ Hospitals. He has a Ph.D. in cancer biology, and a degree in biochemistry from the University of Oxford. Prof Spicer’s research interests include clinical drug development and translational studies. He has established and runs a Phase 1 programme in solid tumour oncology at Guy’s Hospital, where the portfolio of recruiting trials includes a novel antibody class and a CAR-T cell therapy, both discovered and developed at King’s. He directs the King’s Experimental Cancer Medicine Centre (ECMC), funded by Cancer Research UK and the National Institute for Health Research. He is lead for the Immunotherapy Theme of the national ECMC Network, and chair of the Paediatric ECMC national network.